MedTrace Logo

Mefloquine Bioequivalence Among 3 Commercially Available Tablets.

NCT00544024 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 39

Last updated 2007-10-16

No results posted yet for this study

Summary

The objective of this study was to determine the bioequivalence among three commercial tablet formulations of MQ, i.e. Lariam, Mephaquin, and Mefloquine-(AC Farma) when given in combination with artesunate.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Michael D Green, PhD · Centers for Disease Control and Prevention

  • Wilmer Marquino, MD · Instituto Nacional de Salud, Lima, Peru

  • David Bacon, PhD · Naval Medical Research Center Detachment

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-03-31
Completion
2007-03-31

Countries

  • Peru

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00544024 on ClinicalTrials.gov